Luca Prosperini
Luca Prosperini is an expert in Neurology at Azienda Ospedaliera San Camillo-Forlanini (Italy). As of October 2026, ScienceLeadR ranks Luca Prosperini in the top 1% of experts worldwide for Multiple Sclerosis and Autoimmune Diseases. Luca Prosperini has authored 241 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 800 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Immunology - Neurosurgery - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 241
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia. PMID 42371131 — sclerosis, multiple sclerosis, neurosurgery, trigeminal neuralgia, neurology, neuralgia | J Neurol | 2026 | 0 |
| From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis. PMID 42312812 — cytokines, cells, sclerosis, multiple sclerosis, granulocyte-macrophage colony-stimulating factor, interleukin-6, antigen presentation, cladribine, b-lymphocyte subsets, therapeutics, memory, b-lymphocytes | Ann Neurol | 2026 | 1 |
| Rethinking prognosis in multiple sclerosis: a multiaxial perspective. PMID 42156973 — sclerosis, multiple sclerosis, biomarkers, work, research, nervous system diseases, prognosis | Nat Rev Neurol Top journal | 2026 | 0 |
| First pediatric migraine with transient hypoperfusion, venous abnormalities and EEG slowing. PMID 41796399 — migraine disorders, neurosciences | Neurol Sci | 2026 | 0 |
| Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study. PMID 41472694 — sclerosis, multiple sclerosis, antibodies, tablets, cladribine, antibodies, monoclonal, therapeutics | Ther Adv Neurol Disord | 2025 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 6
LeadR Networks
Main global connection map